Artikel ; Online: The role of serum asprosin levels in predicting the severity of coronary artery disease in patients with diabetes mellitus.
Irish journal of medical science
2024 Band 193, Heft 3, Seite(n) 1239–1247
Abstract: Background: Asprosin is an emerging biomarker that plays a role in metabolic diseases. This study investigates asprosin as a predictive marker for coronary artery disease (CAD) severity in diabetic patients.: Methods: Diabetic patients (n = 181) and ... ...
Abstract | Background: Asprosin is an emerging biomarker that plays a role in metabolic diseases. This study investigates asprosin as a predictive marker for coronary artery disease (CAD) severity in diabetic patients. Methods: Diabetic patients (n = 181) and healthy controls (n = 60) were analyzed. CAD severity was assessed using SYNTAX score. Diabetic patients were divided into 3 groups. Group 1 = patients without CAD, group 2 = patients with low SYNTAX score, and group 3 = patients with moderate-high SYNTAX score. Asprosin levels were measured for all participants using an enzyme-linked immunosorbent assay (ELISA). Results: Asprosin levels were significantly higher in patient group compared to control group (p < 0.001). Asprosin levels were significantly higher in group 3 compared to group 1 and group 2 (p = 0.002). In logistic regression analysis, asprosin levels independently predicted patients with moderate-high SYNTAX scores. According to this analysis, 1 ng/mL increase in asprosin level was found to increase the risk of having moderate-high SYNTAX score by 14.1%. When the threshold value of asprosin level was set as 22.17 ng/mL, it predicted patients with moderate-high SYNTAX score with 63.6% sensitivity and 62.6% specificity. In multivariate regression analysis, SYNTAX score independently correlated with asprosin level. Conclusion: This is the first study in the literature to demonstrate a positive correlation between asprosin levels and SYNTAX scores in diabetic patients with CAD. More comprehensive studies with larger groups are needed. |
---|---|
Mesh-Begriff(e) | Humans ; Coronary Artery Disease/blood ; Coronary Artery Disease/complications ; Coronary Artery Disease/diagnostic imaging ; Male ; Female ; Middle Aged ; Fibrillin-1/blood ; Biomarkers/blood ; Severity of Illness Index ; Aged ; Diabetes Mellitus/blood ; Case-Control Studies ; Extracellular Matrix Proteins/blood ; Adipokines |
Chemische Substanzen | Fibrillin-1 ; Biomarkers ; FBN1 protein, human ; Extracellular Matrix Proteins ; Adipokines |
Sprache | Englisch |
Erscheinungsdatum | 2024-02-01 |
Erscheinungsland | Ireland |
Dokumenttyp | Journal Article |
ZDB-ID | 390895-1 |
ISSN | 1863-4362 ; 0021-1265 |
ISSN (online) | 1863-4362 |
ISSN | 0021-1265 |
DOI | 10.1007/s11845-024-03616-6 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.B 323: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.